Page last updated: 2024-10-28

halothane and Cardiomyopathy, Hypertrophic

halothane has been researched along with Cardiomyopathy, Hypertrophic in 2 studies

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research Excerpts

ExcerptRelevanceReference
"When halothane 0."1.26The use of halothane in a patient with asymmetrical septal hypertrophy: a case report. ( Reitan, JA; Wright, RG, 1982)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reitan, JA1
Wright, RG1
Vivien, B1
Hanouz, JL1
Gueugniaud, PY1
Lecarpentier, Y1
Coriat, P1
Riou, B1

Other Studies

2 other studies available for halothane and Cardiomyopathy, Hypertrophic

ArticleYear
The use of halothane in a patient with asymmetrical septal hypertrophy: a case report.
    Canadian Anaesthetists' Society journal, 1982, Volume: 29, Issue:2

    Topics: Anesthesia; Cardiomyopathy, Hypertrophic; Electrocardiography; Halothane; Heart Rate; Humans; Male;

1982
Myocardial effects of halothane and isoflurane in hamsters with hypertrophic cardiomyopathy.
    Anesthesiology, 1997, Volume: 87, Issue:6

    Topics: Anesthetics, Inhalation; Animals; Cardiomyopathy, Hypertrophic; Cricetinae; Depression, Chemical; Fe

1997